-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FuEDNtnqFGVAn+zhqtcd7hMoB81xTg/6Ctx9D6sjXy+aXNjo2mGwA9lrJ9DFXDe4 Ho2mYUWCrJuxpErIwmm2yg== 0000078003-07-000216.txt : 20070829 0000078003-07-000216.hdr.sgml : 20070829 20070829100045 ACCESSION NUMBER: 0000078003-07-000216 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070827 FILED AS OF DATE: 20070829 DATE AS OF CHANGE: 20070829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: pSivida LTD CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: LEVEL 12 BGC CENTRE STREET 2: 28 THE ESPLANADE CITY: PERTH STATE: C3 ZIP: 6000 BUSINESS PHONE: 61 8 9226 5099 MAIL ADDRESS: STREET 1: LEVEL 12 BGC CENTRE STREET 2: 28 THE ESPLANADE CITY: PERTH STATE: C3 ZIP: 6000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 071085548 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER NAME: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2007-08-27 0 0001314102 pSivida LTD PSDV 0000078003 PFIZER INC 235 E 42ND ST NEW YORK NY 10017 0 0 1 0 Ordinary shares 74483748 D This Form 3 is being filed as the result of the determination by pSivida Limited that it is no longer a foreign private issuer and is subject to all of the reporting requirements of the Securities Exchange Act of 1934 and other rules applicable to a U.S. domestic issuer. Lawrence A. Fox, Vice President, Asst. General Counsel & Asst. Secretary on behalf of Pfizer Inc. 2007-08-29 -----END PRIVACY-ENHANCED MESSAGE-----